Search
Recursion Pharmaceuticals Inc
RXRXAdd to Watchlist
3.690USD
+0.170+4.83%
Close 06/29, 16:00（ET）Quotes delayed by 15 min
1.95BMarket Cap
LossP/E TTM
Recursion Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
74.68M
26.92%
EPS(YoY)
-1.44
14.78%
Analyst Rating
HOLD
2026-06-29
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 74.68M, with a year-on-year change of 26.92.
What are the current assets of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its current assets were 812.85M, with a year-on-year change of 13.80.
What are the total assets of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its total assets of Recursion Pharmaceuticals Inc were 1.47B, with a year-on-year change of 1.76.
What are the total liabilities of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Recursion Pharmaceuticals Inc were 343.26M, with a year-on-year change of -17.05.
What is the total equity of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its total equity of Recursion Pharmaceuticals Inc was 1.13B, with a year-on-year change of 9.29.
What is the net investment of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its net investment of Recursion Pharmaceuticals Inc was -16.87M, with a year-on-year change of -106.49.
What is the net financing of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its net financing of Recursion Pharmaceuticals Inc was 521.53M, with a year-on-year change of 71.49.
What is the Earnings Per Share (EPS) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.44, with a year-on-year change of 14.78.
What is the net margin of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -863.35, with a year-on-year change of -9.56.
What is the gross margin of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 4.99, with a year-on-year change of -78.40.
What is the debt-to-asset ratio of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 1.27, with a year-on-year change of -33.21.
What is the Return on Equity (ROE) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -59.54, with a year-on-year change of 3.80.
What is the Return on Assets (ROA) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -44.12, with a year-on-year change of -0.02.
What is the operating profit of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -648.13M, with a year-on-year change of -35.31.
